227 related articles for article (PubMed ID: 24562642)
21. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
22. Effects of iterative reconstruction on image contrast and lesion detection in gamma camera coincidence imaging in lung and breast cancers.
Paul AK; Tatsumi M; Yutani K; Fujino K; Hashikawa K; Nishimura T
Nucl Med Commun; 2002 Jan; 23(1):103-10. PubMed ID: 11748445
[TBL] [Abstract][Full Text] [Related]
23.
Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312
[TBL] [Abstract][Full Text] [Related]
24. Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.
Pritchard KI; Julian JA; Holloway CM; McCready D; Gulenchyn KY; George R; Hodgson N; Lovrics P; Perera F; Elavathil L; O'Malley FP; Down N; Bodurtha A; Shelley W; Levine MN
J Clin Oncol; 2012 Apr; 30(12):1274-9. PubMed ID: 22393089
[TBL] [Abstract][Full Text] [Related]
25. Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.
Seo MJ; Lee JJ; Kim HO; Chae SY; Park SH; Ryu JS; Ahn SH; Lee JW; Son BH; Gong GY; Moon DH
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):438-45. PubMed ID: 24196918
[TBL] [Abstract][Full Text] [Related]
26. Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.
Schwyzer M; Martini K; Benz DC; Burger IA; Ferraro DA; Kudura K; Treyer V; von Schulthess GK; Kaufmann PA; Huellner MW; Messerli M
Eur Radiol; 2020 Apr; 30(4):2031-2040. PubMed ID: 31822970
[TBL] [Abstract][Full Text] [Related]
27. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.
Veronesi U; De Cicco C; Galimberti VE; Fernandez JR; Rotmensz N; Viale G; Spano G; Luini A; Intra M; Veronesi P; Berrettini A; Paganelli G
Ann Oncol; 2007 Mar; 18(3):473-8. PubMed ID: 17164229
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.
Kitajima K; Fukushima K; Miyoshi Y; Katsuura T; Igarashi Y; Kawanaka Y; Mouri M; Maruyama K; Yamano T; Doi H; Yamakado K; Hirota S; Hirota S
Jpn J Radiol; 2016 Mar; 34(3):220-8. PubMed ID: 26715510
[TBL] [Abstract][Full Text] [Related]
29. 18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction.
Teoh EJ; McGowan DR; Bradley KM; Belcher E; Black E; Moore A; Sykes A; Gleeson FV
Eur Radiol; 2016 Nov; 26(11):4098-4106. PubMed ID: 26914696
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.
Heusner TA; Kuemmel S; Hahn S; Koeninger A; Otterbach F; Hamami ME; Kimmig KR; Forsting M; Bockisch A; Antoch G; Stahl A
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1543-50. PubMed ID: 19415270
[TBL] [Abstract][Full Text] [Related]
31. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters.
Akamatsu G; Ishikawa K; Mitsumoto K; Taniguchi T; Ohya N; Baba S; Abe K; Sasaki M
J Nucl Med; 2012 Nov; 53(11):1716-22. PubMed ID: 22952340
[TBL] [Abstract][Full Text] [Related]
32. Changes of [
Liu Y; Gao MJ; Zhou J; Du F; Chen L; Huang ZK; Hu JB; Lou C
BMC Med Imaging; 2021 Sep; 21(1):133. PubMed ID: 34530768
[TBL] [Abstract][Full Text] [Related]
33. Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET/CT.
Lee YS; Kim JS; Kim KM; Kang JH; Lim SM; Kim HJ
Ann Nucl Med; 2014 May; 28(4):340-8. PubMed ID: 24504938
[TBL] [Abstract][Full Text] [Related]
34. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Aukema TS; Straver ME; Peeters MJ; Russell NS; Gilhuijs KG; Vogel WV; Rutgers EJ; Olmos RA
Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
[TBL] [Abstract][Full Text] [Related]
35. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Yutani K; Tatsumi M; Shiba E; Kusuoka H; Nishimura T
J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
[TBL] [Abstract][Full Text] [Related]
36. Preoperative FDG-PET for axillary metastases in patients with breast cancer.
Chung A; Liou D; Karlan S; Waxman A; Fujimoto K; Hagiike M; Phillips EH
Arch Surg; 2006 Aug; 141(8):783-8; discussion 788-9. PubMed ID: 16924086
[TBL] [Abstract][Full Text] [Related]
37. The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.
Rogasch JM; Steffen IG; Hofheinz F; Großer OS; Furth C; Mohnike K; Hass P; Walke M; Apostolova I; Amthauer H
EJNMMI Res; 2015; 5():31. PubMed ID: 25992306
[TBL] [Abstract][Full Text] [Related]
38. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
Ahn JH; Son EJ; Kim JA; Youk JH; Kim EK; Kwak JY; Ryu YH; Jeong J
Acta Radiol; 2010 Oct; 51(8):859-65. PubMed ID: 20670083
[TBL] [Abstract][Full Text] [Related]
39. Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
Parvizi N; Franklin JM; McGowan DR; Teoh EJ; Bradley KM; Gleeson FV
Eur J Radiol; 2015 Oct; 84(10):1873-8. PubMed ID: 26163992
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J
J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]